Cardioversion of Atrial Flutter in Patients with Cardiac Pacemakers

Safety and Device Integrity

Cardioversion of atrial flutter is safe in patients with implanted pacemakers when established protocols are followed, with protective device circuitry mitigating external electrical discharge risks. [1][2]
Although pacemaker generators protect against external shocks, current surges can alter programmed data and electricity conducted along implanted leads may cause endocardial injury. [1][2]

Pre‑Procedure Evaluation

Perform a complete pacemaker interrogation before cardioversion to record baseline function, programming parameters, and pacing thresholds, establishing a reference for post‑procedure comparison. 2

Technical Considerations

Paddle Positioning

Use an anterior‑posterior paddle configuration with the paddles placed as far as possible from the pacemaker generator to minimise the risk of device damage and exit block. [1][2]
Avoid the anterior‑apex paddle configuration when a pacemaker is present, as it markedly increases the likelihood of exit block. [1][2]

Energy Selection

For biphasic waveforms, the median successful energy level is approximately 100 J; monophasic waveforms typically require a median of 200 J. 2

Synchronization and Electrolyte Management

Deliver synchronized shocks by aligning the discharge with the QRS complex (monitoring the R‑wave) to ensure effective cardioversion and reduce inappropriate capture. [1][2]
Verify that serum potassium is within the normal range before cardioversion to promote safety and efficacy. 2

Post‑Procedure Management

Immediately re‑interrogate the pacemaker after cardioversion to identify any changes in programmed parameters, pacing thresholds, or impedance values. 2
Current surges may modify programmed data and can produce temporary or permanent increases in stimulation thresholds, potentially leading to loss of ventricular capture; detection requires prompt interrogation. [1][2]

Understanding and Mitigating Risks

The principal mechanisms of pacemaker injury during cardioversion are exit block and endocardial injury from conducted electricity. 2

Practical Algorithm for Pacemaker‑Dependent Patients

All statements are supported by the cited evidence.

Cardioversion in Patients with Pacemakers

Key Safety Principles

The American College of Cardiology and European Heart Society recommend proper paddle positioning, using an anterior-posterior configuration with paddles positioned as far as possible from the pacemaker generator, to reduce the risk of device damage and exit block in patients with pacemakers undergoing cardioversion 3, 4, 5
The European Heart Society and American College of Cardiology suggest that interrogating the pacemaker before and after cardioversion is crucial to document baseline function and programming, and to detect any alterations in programmed parameters or threshold changes 4, 5, 6

Mandatory Pre- and Post-Procedure Steps

The American College of Cardiology recommends reprogramming the device if necessary, based on post-cardioversion interrogation findings, to ensure proper pacemaker function 4, 5

Understanding the Risks

The European Heart Journal and American College of Cardiology report that the primary mechanisms of pacemaker damage during cardioversion include exit block, endocardial injury, device reprogramming or reset, and complete battery discharge 3, 4, 5

Protective Measures During the Procedure

The American College of Cardiology and European Heart Society advise using anterior-posterior configuration exclusively, positioning paddles as distant as possible from the generator, and never placing paddles in the anterior-apex configuration when a pacemaker is present 3, 4, 5
The European Heart Journal suggests that bipolar lead systems carry lower risk than unipolar systems 3, 4

Energy Considerations

The American College of Cardiology recommends starting with appropriate energy levels, such as 200 J for biphasic waveforms, and considering higher initial energy to reduce total number of shocks needed 4, 5, 6

Special Consideration for Pacemaker-Dependent Patients

The Journal of the American College of Cardiology suggests that for patients who are pacemaker-dependent, additional precautions are essential, including ensuring external pacing capability is immediately available and monitoring continuously after cardioversion until stable pacemaker function is confirmed 7, 8

Bottom Line Algorithm

The American College of Cardiology and European Heart Society recommend identifying pacemaker dependence, interrogating the device, positioning paddles anterior-posterior, ensuring backup pacing available, delivering cardioversion with appropriate energy, and immediately re-interrogating the device and reprogramming if needed 3, 4, 5, 6, 7, 8

Guidelines for Cardioversion in Patients with Pacemakers

Safety and Endorsement

Cardioversion of atrial fibrillation or flutter in patients with implanted pacemakers is considered safe and feasible when specific protocols (anterior‑posterior paddle placement, mandatory pre‑ and post‑procedure interrogation) are followed, and it is endorsed by major cardiology societies. [9][10]

Pre‑Procedure Assessment

Device interrogation – Prior to cardioversion, the pacemaker must be interrogated to record baseline programming, pacing thresholds, and impedance values. [9][10]11
Pacemaker dependence evaluation – Determine dependence by reviewing history of symptomatic bradyarrhythmia, prior AV‑node ablation, or inadequate intrinsic escape rhythm. 12
Electrolyte verification – Serum potassium should be confirmed within the normal range to lower the risk of peri‑procedural arrhythmias. [9][10]
Digitalis toxicity screening – Exclude digoxin toxicity based on clinical assessment rather than relying solely on serum levels. [9][10]

Technical Procedure

Paddle Positioning

Use an anterior‑posterior (AP) paddle configuration and place the paddles as far as possible from the pacemaker generator to minimize current flow through the device. [13][9][10][11]12
Avoid anterior‑apex positioning; this configuration markedly increases the risk of exit block. [9][10]
AP positioning reduces the likelihood of direct current passage through the device and lessens endocardial injury. [9][10]

Energy Selection

Initiate cardioversion with 200 J for biphasic waveforms (or 200–360 J for monophasic waveforms). 9
Biphasic waveforms are preferred because they achieve conversion with lower cumulative energy (median ≈ 100 J) compared with monophasic (≈ 200 J). 9

Synchronization

Deliver synchronized shocks timed to the QRS complex to avoid induction of ventricular fibrillation. [9][14]

Risks and Complications

Exit block may occur due to endocardial injury at the electrode‑myocardium interface. 10
Threshold elevation (temporary or permanent) can lead to loss of ventricular capture. 10
Device reset to safety mode has been reported following high‑energy shocks. 12

Post‑Procedure Management

Immediate post‑shock interrogation is required to detect any changes in pacing thresholds, sensing, or impedance. [9][10][11][12]
Reprogramming of the pacemaker should be performed if interrogation reveals abnormal parameters. [9][10]
External pacing backup must be available throughout the procedure and recovery period. [13][11]12
Continuous monitoring should continue until stable pacemaker function is confirmed. [11][12]

Special Considerations for Pacemaker‑Dependent Patients

For patients who are pacemaker‑dependent, consider pre‑operative reprogramming to an asynchronous (VOO/DOO) or triggered mode to prevent inhibition during shock delivery. 15
Ensure transcutaneous or transvenous pacing is immediately accessible. 10
Do not postpone emergent cardioversion for device interrogation when the patient is hemodynamically unstable, has ongoing myocardial ischemia, or presents with symptomatic hypotension/heart failure. [16][9]

Practical Algorithm (Key Steps)

Common Pitfalls to Avoid

Do not use anterior‑apex paddle positioning in patients with pacemakers. [9][10]
Do not delay emergent cardioversion for device interrogation when the patient is unstable. [16][9]
Do not rely solely on therapeutic digoxin levels to rule out toxicity; clinical assessment remains essential. [9][10]